1. Smith TW, MacKenzie J. Personality and risk of physical illness. Annu Rev Clin Psychol. 2006; 2:435–467.
2. Bagby RM, Ryder AG. Personality and the affective disorders: past efforts, current models, and future directions. Curr Psychiatry Rep. 2000; 2:465–472.
3. Cloninger CR, Svrakic DM, Przybeck TR. Can personality assessment predict future depression? A twelve-month follow-up of 631 subjects. J Affect Disord. 2006; 92:35–44.
4. Poletti M, Bonuccelli U. Personality traits in patients with Parkinson's disease: assessment and clinical implications. J Neurol. 2012; 259:1029–1038.
5. Boz C, Velioglu S, Ozmenoglu M, Sayar K, Alioglu Z, Yalman B, et al. Temperament and character profiles of patients with tension-type headache and migraine. Psychiatry Clin Neurosci. 2004; 58:536–543.
6. Conrad R, Schilling G, Bausch C, Nadstawek J, Wartenberg HC, Wegener I, et al. Temperament and character personality profiles and personality disorders in chronic pain patients. Pain. 2007; 133:197–209.
7. Yazici E, Yazici AB, Aydin N, Orhan A, Kirpinar I, Acemoglu H. Temperament and character traits in patients with epilepsy: epileptic personality. J Nerv Ment Dis. 2013; 201:365–370.
8. Cloninger CR. The science of well-being: an integrated approach to mental health and its disorders. World Psychiatry. 2006; 5:71–76.
9. Kampman O, Poutanen O, Illi A, Setälä-Soikkeli E, Viikki M, Nuolivirta T, et al. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients. Eur Psychiatry. 2012; 27:245–249.
10. Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012; 16:283–295.
11. Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med. 2005; 165:1286–1292.
12. Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004; 75:226–230.
13. Lee HB, Hening WA, Allen RP, Kalaydjian AE, Earley CJ, Eaton WW, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008; 20:101–105.
14. Kalaydjian A, Bienvenu OJ, Hening WA, Allen RP, Eaton WW, Lee HB. Restless Legs Syndrome and the five-factor model of personality: results from a community sample. Sleep Med. 2009; 10:672–675.
15. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993; 50:975–990.
16. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987; 44:573–588.
17. Gillespie NA, Cloninger CR, Heath AC, Martina NG. The genetic and environmental relationship between Cloninger's dimensions of temperament and character. Pers Individ Dif. 2003; 35:1931–1946.
18. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561–571.
19. Hisli N. Beck Depresyon Envanteri'nin üniversite öğrencileri için geçerliği, güvenirliği. Psikoloji Dergisi. 1989; 7:3–13.
20. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003; 4:101–119.
21. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003; 4:121–132.
22. Kose S, Sayar K, Kalelioglu U, Aydin N, Celikel FC, Gulec H, et al. Normative data and factorial structure of the Turkish version of the Temperament and Character Inventory. Compr Psychiatry. 2009; 50:361–368.
23. Trouillet R, Gana K. Age differences in temperament, character and depressive mood: a cross-sectional study. Clin Psychol Psychother. 2008; 15:266–275.
24. De Fruyt F, Van De Wiele L, Van Heeringen C. Cloninger's psychobiological model of temperament and character and the five-factor model of personality. Pers Individ Dif. 2000; 29:441–452.
25. Mochcovitch MD, Nardi AE, Cardoso A. Temperament and character dimensions and their relationship to major depression and panic disorder. Rev Bras Psiquiatr. 2012; 34:342–351.
26. Kim WH, Kim BS, Kim SK, Chang SM, Lee DW, Cho MJ, et al. Restless legs syndrome in older people: a community-based study on its prevalence and association with major depressive disorder in older Korean adults. Int J Geriatr Psychiatry. 2012; 27:565–572.
27. Li Y, Mirzaei F, O'Reilly EJ, Winkelman J, Malhotra A, Okereke OI, et al. Prospective study of restless legs syndrome and risk of depression in women. Am J Epidemiol. 2012; 176:279–288.
28. Gupta R, Lahan V, Goel D. A study examining depression in restless legs syndrome. Asian J Psychiatr. 2013; 6:308–312.
29. Sugiura M, Kawashima R, Nakagawa M, Okada K, Sato T, Goto R, et al. Correlation between human personality and neural activity in cerebral cortex. Neuroimage. 2000; 11(5 Pt 1):541–546.
30. Moresco FM, Dieci M, Vita A, Messa C, Gobbo C, Galli L, et al. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage. 2002; 17:1470–1478.
31. Karlsson H, Hirvonen J, Salminen JK, Hietala J. No association between serotonin 5-HT 1A receptors and spirituality among patients with major depressive disorders or healthy volunteers. Mol Psychiatry. 2011; 16:282–285.
32. Tuominen L, Salo J, Hirvonen J, Någren K, Laine P, Melartin T, et al. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort. Psychol Med. 2013; 43:881–894.
33. Yasuno F, Suhara T, Sudo Y, Yamamoto M, Inoue M, Okubo Y, et al. Relation among dopamine D(2) receptor binding, obesity and personality in normal human subjects. Neurosci Lett. 2001; 300:59–61.
34. Kim JH, Son YD, Kim HK, Lee SY, Cho SE, Kim YB, et al. Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: a high resolution PET study. Biol Psychol. 2011; 87:164–167.
35. Alex KD, Pehek EA. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol Ther. 2007; 113:296–320.
36. Bayard M, Bailey B, Acharya D, Ambreen F, Duggal S, Kaur T, et al. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2011; 24:422–428.
37. Jhoo JH, Yoon IY, Kim YK, Chung S, Kim JM, Lee SB, et al. Availability of brain serotonin transporters in patients with restless legs syndrome. Neurology. 2010; 74:513–518.
38. Iwamoto R, Yamawaki N, Sato T. Increased self-transcendence in patients with intractable diseases. Psychiatry Clin Neurosci. 2011; 65:638–647.
39. Cloninger CR, Zohar AH. Personality and the perception of health and happiness. J Affect Disord. 2011; 128:24–32.
40. Winkelman JW. Considering the causes of RLS. Eur J Neurol. 2006; 13:Suppl 3. 8–14.
41. Tomer R, Aharon-Peretz J. Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency. J Neurol Neurosurg Psychiatry. 2004; 75:972–975.
42. Salas RE, Gamaldo CE, Allen RP. Update in restless legs syndrome. Curr Opin Neurol. 2010; 23:401–406.